| 000 | 01688 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515103036.0 | ||
| 264 | 0 | _c20080915 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a0049-3848 | ||
| 024 | 7 |
_a10.1016/j.thromres.2007.10.025 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmit, Jaap Jan J | |
| 245 | 0 | 0 |
_aChange of white blood cell count more prognostic important than baseline values after primary percutaneous coronary intervention for ST elevation myocardial infarction. _h[electronic resource] |
| 260 |
_bThrombosis research _c2008 |
||
| 300 |
_a185-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngioplasty, Balloon, Coronary _xmethods |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukocytes _xcytology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xmetabolism |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTirofiban |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTyrosine _xanalogs & derivatives |
| 700 | 1 | _aOttervanger, Jan Paul | |
| 700 | 1 | _aKolkman, J J Evelien | |
| 700 | 1 | _aSlingerland, Robbert J | |
| 700 | 1 | _aSuryapranata, Harry | |
| 700 | 1 | _aHoorntje, Jan C A | |
| 700 | 1 | _aDambrink, Jan-Henk E | |
| 700 | 1 | _aGosselink, A T Marcel | |
| 700 | 1 | _ade Boer, Menko Jan | |
| 700 | 1 | _avan 't Hof, Arnoud W J | |
| 773 | 0 |
_tThrombosis research _gvol. 122 _gno. 2 _gp. 185-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.thromres.2007.10.025 _zAvailable from publisher's website |
| 999 |
_c17675404 _d17675404 |
||